Literature DB >> 14766207

A heat shock protein70 fusion protein with alpha1-antitrypsin in plasma of type 1 diabetic subjects.

Paola Finotti1, Andrea Pagetta.   

Abstract

The recent observation that heat shock proteins (HSPs), mostly glucose regulated protein94 (Grp94) and HSP70, are present in plasma of Type 1 diabetic subjects as complexes with immunoglobulins, prompted us to investigate the nature and extent of this association, whether it represents HSP-induced activation of the immune system. Two complementary affinity chromatography procedures followed by immunoprecipitation and immunoblot analyses of HSP-enriched, plasma-purified peaks, revealed that HSPs were inextricably linked with IgG in SDS-resistant complexes from which proteins dissociate partially under reducing treatment. HSP70 was found also closely linked with alpha1-antitrypsin (alpha1AT) in a single protein having the mass of alpha1AT but elution characteristics different from those of normal alpha1AT. Immunoprecipitation with anti-HSP70 antibodies led to co-immunoprecipitation of the alpha1AT species linked to HSP70, thus confirming fusion of the proteins. The additional finding of circulating antibodies against the HSP70-alpha1AT protein supported its immunogenic properties with implications for diabetes and its complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766207     DOI: 10.1016/j.bbrc.2004.01.058

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes.

Authors:  Gabriella Fleixo-Lima; Hilla Ventura; Michal Medini; Liliana Bar; Pnina Strauss; Eli C Lewis
Journal:  J Diabetes Sci Technol       Date:  2014-08-25

Review 2.  Extracellular cell stress (heat shock) proteins-immune responses and disease: an overview.

Authors:  A Graham Pockley; Brian Henderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

Review 3.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 4.  Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.

Authors:  O Guttman; B M Baranovski; R Schuster; Z Kaner; G S Freixo-Lima; N Bahar; N Kalay; M I Mizrahi; I Brami; D E Ochayon; E C Lewis
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

5.  Alpha-1 Antitrypsin Therapy for Autoimmune Disorders.

Authors:  Sihong Song
Journal:  Chronic Obstr Pulm Dis       Date:  2018-10-05

6.  α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α.

Authors:  Angelia D Lockett; Samuel Kimani; Godfrey Ddungu; Sabine Wrenger; Rubin M Tuder; Sabina M Janciauskiene; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

7.  Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.

Authors:  Boris M Baranovski; Eyal Ozeri; Galit Shahaf; David E Ochayon; Ronen Schuster; Nofar Bahar; Noa Kalay; Pablo Cal; Mark I Mizrahi; Omer Nisim; Pnina Strauss; Eran Schenker; Eli C Lewis
Journal:  J Pharmacol Exp Ther       Date:  2016-11-07       Impact factor: 4.030

8.  Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties.

Authors:  Yotam Lior; Mariana Zaretsky; David E Ochayon; Diana Lotysh; Boris M Baranovski; Ronen Schuster; Ofer Guttman; Amir Aharoni; Eli C Lewis
Journal:  Front Immunol       Date:  2018-05-01       Impact factor: 7.561

9.  Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo.

Authors:  David E Ochayon; Mark Mizrahi; Galit Shahaf; Boris M Baranovski; Eli C Lewis
Journal:  Front Immunol       Date:  2013-10-28       Impact factor: 7.561

10.  In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer Protein.

Authors:  Fatemeh Fotouhi; Behrokh Farahmand; Behnaz Heidarchi; Maryam Esghaei; Sima Rafati; Masoumeh Tavassoti Kheiri
Journal:  Jundishapur J Microbiol       Date:  2014-09-01       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.